- According to the
World Health Organization(WHO), depression is the leading cause of disability worldwide.
- It affects at least 5% of adults, with more women than men experiencing depression symptoms.
- A multinational study has found that people with depression symptoms are more likely to experience a stroke, and their recovery from stroke is often more difficult.
- In this study, people with symptoms of depression had a 46% increased stroke risk compared with those without such symptoms.
Depression affects approximately
Psychological symptoms of depression include persistently depressed mood, feelings of worthlessness, loss of interest in pleasurable activities, difficulty concentrating, and even thoughts of suicide.
In addition, depression may cause physical symptoms, such as fatigue, lack of appetite, headaches, chronic pain, and digestive issues.
Research has also linked depression with cardiovascular disease (CVD), with
Now, an international study, published in Neurology, has found that people with depressive symptoms have an increased risk of both ischemic and hemorrhagic stroke, and worse recovery after a stroke.
Dr. Curtis Benesch, medical director of the University of Rochester Medical Center Comprehensive Stroke Center, not involved in this study, commented on the findings for Medical News Today:
“This paper describes a well-done observational study. It relies on self-reported symptoms of depression, though, and there is some subjectivity in that. […] However, the authors have done an excellent job in generating the potential impact of a prior stroke by matching cases with controls that mirror age, other risk factors, race and ethnicity, and to some extent location.”
The research investigated 26,877 adults from the
More than 13,000 participants had a stroke. The researchers matched them for age, sex, and racial or ethnic identity with another group of more than 13,000 participants who had not had a stroke. All completed questionnaires about cardiovascular risk factors, such as hypertension and diabetes.
The researchers collected information about depressive symptoms in the year leading up to the study. They asked participants whether they had felt sad or depressed for 2 or more consecutive weeks during those 12 months.
To assess whether participants might have chronic low mood, the researchers asked whether they had given up on making life improvements. They also recorded whether participants had ever taken antidepressants.
Those who had a stroke were more likely to have experienced depressive symptoms (18%) than those who did not have a stroke (14%). Those who reported having “given up on making life improvements” had a greater risk of stroke.
When the researchers adjusted for age, sex, education, physical activity, and other lifestyle factors, people with symptoms of depression had a 46% increased risk of stroke over those with no such symptoms.
The researchers found that the association between depressive symptoms and stroke was consistent across all country-income levels.
People with four or more depression symptoms were at higher risk of stroke than those with fewer symptoms.
Dr. Benesch commented on this finding, noting that “[t]his association between more severe depression and stroke risk is certainly worthy of more exploration and could be clinically significant.”
“An analogy would be that we know that smoking causes lung cancer. We also know that heavy smoking is more likely to cause lung cancer in someone who smokes every day versus someone who smokes once every 6 months. So there appears to be a dose-response relationship,” he added.
The study also found that although people with depressive symptoms did not have more severe strokes, they had worse outcomes 1 month after the stroke.
“These findings, at the bare minimum, should generate further investigation into this association between the two conditions. If that carries forward and we start to get some understanding of causality, then we can start talking about mitigating strategies.”
– Dr. Curtis Benesch
Several studies have previously linked depression with heart disease and stroke.
Although the association was modest, it was present even in people whose symptoms were below the level of a depressive disorder.
This study did not identify the mechanisms by which depression might increase stroke risk, and previous studies have also been unable to do so.
Studies have also shown that depression can lead to people engaging in more adverse health behaviors, such as smoking and not complying with medical treatments. These behaviors may contribute to the risk of CVD and stroke.
Dr. Sandra Narayanan, board-certified vascular neurologist and neurointerventional surgeon at Pacific Stroke & Neurovascular Center at Pacific Neuroscience Institute in Santa Monica, CA, not involved in the current study, suggested another possibility.
“Depressive symptoms can be associated with increased stress, which can independently increase inflammation, [the] risk for future cardiovascular and cerebrovascular disease, and morbidity,” she said.
While the mechanisms that increase the risk may be unclear, this study shows that people with depression symptoms do have a higher likelihood of stroke and worse recovery from stroke. These findings suggest possible therapeutic pathways that may be effective.
People taking antidepressant medication did not have the same increased stroke risk as those with depression symptoms that were not treated with antidepressants.
The authors suggest that appropriate treatment might therefore lessen the risk of stroke. However, they caution that these medications may have other harmful effects.
For those with less severe depression symptoms, they suggest that psychological interventions might be an effective approach.
Dr. Narayanan advised that the findings could inform treatments, noting that “[e]ducating patients undergoing treatment for depression, as well as screening those at risk for depression about their future stroke risk, is an important public health strategy, based on these study findings.”
“Including caregivers and PCPs [primary care physicians] in treatment plans and advising them of the additive risk of untreated depression is essential for longitudinal surveillance and treatment of cerebrovascular disease,” she added.